{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T15:09:15Z","timestamp":1794236955883,"version":"4.9.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060551"],"award-info":[{"award-number":["82060551"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060666"],"award-info":[{"award-number":["82060666"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-024-05664-z","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T09:01:58Z","timestamp":1727686918000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["N-acetyltransferase 10 affects the proliferation of intrahepatic cholangiocarcinoma and M2-type polarization of macrophages by regulating C-C motif chemokine ligand 2"],"prefix":"10.1186","volume":"22","author":[{"given":"Teng","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianye","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongtian","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingdong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9355-0225","authenticated-orcid":false,"given":"Wenbo","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"key":"5664_CR1","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","volume":"145","author":"S Rizvi","year":"2013","unstructured":"Rizvi S, Gores GJ. Pathogenesis, diagnosis, and management of Cholangiocarcinoma. Gastroenterology. 2013;145:1215\u201329.","journal-title":"Gastroenterology"},{"key":"5664_CR2","first-page":"95","volume":"15","author":"S Rizvi","year":"2017","unstructured":"Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Cholangiocarcinoma \u2014 evolving concepts and therapeutic strategies. Nat Reviews Clin Oncol. 2017;15:95\u2013111.","journal-title":"Nat Reviews Clin Oncol"},{"key":"5664_CR3","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/S0168-8278(02)00297-0","volume":"37","author":"SA Khan","year":"2002","unstructured":"Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol. 2002;37:806\u201313.","journal-title":"J Hepatol"},{"key":"5664_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2407-2-10","volume":"2","author":"T Patel","year":"2002","unstructured":"Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer. 2002;2:10.","journal-title":"BMC Cancer"},{"key":"5664_CR5","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","volume":"60","author":"J Bridgewater","year":"2014","unstructured":"Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, Pawlik TM, Gores GJ. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60:1268\u201389.","journal-title":"J Hepatol"},{"key":"5664_CR6","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1002\/cncr.29619","volume":"121","author":"G Spolverato","year":"2015","unstructured":"Spolverato G, Vitale A, Cucchetti A, Popescu I, Marques HP, Aldrighetti L, Gamblin TC, Maithel SK, Sandroussi C, Bauer TW, et al. Can hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma? Cancer. 2015;121:3998\u20134006.","journal-title":"Cancer"},{"key":"5664_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1245\/s10434-023-14488-y","volume":"31","author":"S Franssen","year":"2024","unstructured":"Franssen S, Holster JJ, Jolissaint JS, Nooijen LE, Cercek A, D\u2019Angelica MI, Homs MYV, Wei AC, Balachandran VP, Drebin JA, et al. Gemcitabine with Cisplatin Versus hepatic arterial infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma. Ann Surg Oncol. 2024;31:115\u201324.","journal-title":"Ann Surg Oncol"},{"key":"5664_CR8","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.cell.2018.10.030","volume":"175","author":"D Arango","year":"2018","unstructured":"Arango D, Sturgill D, Alhusaini N, Dillman AA, Sweet TJ, Hanson G, Hosogane M, Sinclair WR, Nanan KK, Mandler MD, et al. Acetylation of Cytidine in mRNA promotes translation efficiency. Cell. 2018;175:1872\u2013e18861824.","journal-title":"Cell"},{"key":"5664_CR9","doi-asserted-by":"publisher","first-page":"2274143","DOI":"10.1080\/15384047.2023.2274143","volume":"24","author":"Z Li","year":"2023","unstructured":"Li Z, Li D, Yang T, Yao C. NAT10 promotes the tumorigenesis and progression of laryngeal squamous cell carcinoma through ac4C modification of FOXM1 mRNA. Cancer Biol Ther. 2023;24:2274143.","journal-title":"Cancer Biol Ther"},{"key":"5664_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41420-023-01355-8","volume":"9","author":"Z Pan","year":"2023","unstructured":"Pan Z, Bao Y, Hu M, Zhu Y, Tan C, Fan L, Yu H, Wang A, Cui J, Sun G. Role of NAT10-mediated ac4C-modified HSP90AA1 RNA acetylation in ER stress-mediated metastasis and lenvatinib resistance in hepatocellular carcinoma. Cell Death Discovery. 2023;9:56.","journal-title":"Cell Death Discovery"},{"key":"5664_CR11","doi-asserted-by":"publisher","first-page":"e2302705","DOI":"10.1002\/advs.202302705","volume":"10","author":"X Chen","year":"2023","unstructured":"Chen X, Hao Y, Liu Y, Zhong S, You Y, Ao K, Chong T, Luo X, Yin M, Ye M, et al. NAT10\/ac4C\/FOXP1 promotes malignant progression and facilitates immunosuppression by reprogramming glycolytic metabolism in Cervical Cancer. Adv Sci. 2023;10:e2302705.","journal-title":"Adv Sci"},{"key":"5664_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41392-021-00489-4","volume":"6","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Jing Y, Wang Y, Tang J, Zhu X, Jin WL, Wang Y, Yuan W, Li X, Li X. NAT10 promotes gastric cancer metastasis via N4-acetylated COL5A1. Signal Transduct Target Ther. 2021;6:173.","journal-title":"Signal Transduct Target Ther"},{"key":"5664_CR13","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/imm.12910","volume":"154","author":"SC Funes","year":"2018","unstructured":"Funes SC, Rios M, Escobar-Vera J, Kalergis AM. Implications of macrophage polarization in autoimmunity. Immunology. 2018;154:186\u201395.","journal-title":"Immunology"},{"key":"5664_CR14","doi-asserted-by":"crossref","unstructured":"Arneth B. Tumor Microenvironment. Medicina (Kaunas) 2019, 56.","DOI":"10.3390\/medicina56010015"},{"key":"5664_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2217\/imt-2016-0135","volume":"9","author":"AJ Petty","year":"2017","unstructured":"Petty AJ, Yang Y. Tumor-associated macrophages: implications in cancer immunotherapy. Immunotherapy. 2017;9:289\u2013302.","journal-title":"Immunotherapy"},{"key":"5664_CR16","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.4049\/jimmunol.1302821","volume":"192","author":"E Sierra-Filardi","year":"2014","unstructured":"Sierra-Filardi E, Nieto C, Dom\u00ednguez-Soto A, Barroso R, S\u00e1nchez-Mateos P, Puig-Kroger A, L\u00f3pez-Bravo M, Joven J, Ardav\u00edn C, Rodr\u00edguez-Fern\u00e1ndez JL, et al. CCL2 shapes macrophage polarization by GM-CSF and M-CSF: identification of CCL2\/CCR2-dependent gene expression profile. J Immunol. 2014;192:3858\u201367.","journal-title":"J Immunol"},{"key":"5664_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","volume":"26","author":"Y Chen","year":"2019","unstructured":"Chen Y, Song Y, Du W, Gong L, Chang H, Zou Z. Tumor-associated macrophages: an accomplice in solid tumor progression. J Biomed Sci. 2019;26:78.","journal-title":"J Biomed Sci"},{"key":"5664_CR18","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/emmm.201202367","volume":"5","author":"K Izumi","year":"2013","unstructured":"Izumi K, Fang LY, Mizokami A, Namiki M, Li L, Lin WJ, Chang C. Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2\/CCR2-induced STAT3 activation. EMBO Mol Med. 2013;5:1383\u2013401.","journal-title":"EMBO Mol Med"},{"key":"5664_CR19","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.3390\/cancers6031670","volume":"6","author":"T Chanmee","year":"2014","unstructured":"Chanmee T, Ontong P, Konno K, Itano N. Tumor-associated macrophages as major players in the tumor microenvironment. Cancers (Basel). 2014;6:1670\u201390.","journal-title":"Cancers (Basel)"},{"key":"5664_CR20","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/jlb.60.3.365","volume":"60","author":"LL Xu","year":"1996","unstructured":"Xu LL, Warren MK, Rose WL, Gong W, Wang JM. Human recombinant monocyte chemotactic protein and other C-C chemokines bind and induce directional migration of dendritic cells in vitro. J Leukoc Biol. 1996;60:365\u201371.","journal-title":"J Leukoc Biol"},{"key":"5664_CR21","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1073\/pnas.91.9.3652","volume":"91","author":"MW Carr","year":"1994","unstructured":"Carr MW, Roth SJ, Luther E, Rose SS, Springer TA. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci U S A. 1994;91:3652\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5664_CR22","doi-asserted-by":"publisher","first-page":"28697","DOI":"10.18632\/oncotarget.7376","volume":"7","author":"SY Lim","year":"2016","unstructured":"Lim SY, Yuzhalin AE, Gordon-Weeks AN, Muschel RJ. Targeting the CCL2-CCR2 signaling axis in cancer metastasis. Oncotarget. 2016;7:28697\u2013710.","journal-title":"Oncotarget"},{"key":"5664_CR23","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1387\/ijdb.041814hk","volume":"48","author":"H Kulbe","year":"2004","unstructured":"Kulbe H, Levinson NR, Balkwill F, Wilson JL. The chemokine network in cancer\u2013much more than directing cell movement. Int J Dev Biol. 2004;48:489\u201396.","journal-title":"Int J Dev Biol"},{"key":"5664_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/cmi.2017.135","volume":"15","author":"T Yoshimura","year":"2018","unstructured":"Yoshimura T. The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally? Cell Mol Immunol. 2018;15:335\u201345.","journal-title":"Cell Mol Immunol"},{"key":"5664_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12943-020-01165-x","volume":"19","author":"H Yang","year":"2020","unstructured":"Yang H, Zhang Q, Xu M, Wang L, Chen X, Feng Y, Li Y, Zhang X, Cui W, Jia X. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis. Mol Cancer. 2020;19:41.","journal-title":"Mol Cancer"},{"key":"5664_CR26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/cas.14230","volume":"111","author":"D Li","year":"2019","unstructured":"Li D, Ji H, Niu X, Yin L, Wang Y, Gu Y, Wang J, Zhou X, Zhang H, Zhang Q. Tumor-associated macrophages secrete CC\u2010chemokine ligand 2 and induce tamoxifen resistance by activating PI3K\/Akt\/mTOR in breast cancer. Cancer Sci. 2019;111:47\u201358.","journal-title":"Cancer Sci"},{"key":"5664_CR27","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/s41419-021-04166-w","volume":"12","author":"W Tu","year":"2021","unstructured":"Tu W, Gong J, Zhou Z, Tian D, Wang Z. TCF4 enhances hepatic metastasis of colorectal cancer by regulating tumor-associated macrophage via CCL2\/CCR2 signaling. Cell Death Dis. 2021;12:882.","journal-title":"Cell Death Dis"},{"key":"5664_CR28","doi-asserted-by":"publisher","first-page":"R14","DOI":"10.1186\/gb-2010-11-2-r14","volume":"11","author":"MD Young","year":"2010","unstructured":"Young MD, Wakefield MJ, Smyth GK, Oshlack A. Gene ontology analysis for RNA-seq: accounting for selection bias. Genome Biol. 2010;11:R14.","journal-title":"Genome Biol"},{"key":"5664_CR29","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1093\/bioinformatics\/bti430","volume":"21","author":"X Mao","year":"2005","unstructured":"Mao X, Cai T, Olyarchuk JG, Wei L. Automated genome annotation and pathway identification using the KEGG Orthology (KO) as a controlled vocabulary. Bioinformatics. 2005;21:3787\u201393.","journal-title":"Bioinformatics"},{"key":"5664_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open Babel: an open chemical toolbox. J Cheminform. 2011;3:33.","journal-title":"J Cheminform"},{"key":"5664_CR31","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S. AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python Bindings. J Chem Inf Model. 2021;61:3891\u20138.","journal-title":"J Chem Inf Model"},{"key":"5664_CR32","doi-asserted-by":"crossref","unstructured":"Del Conte A, Monzon AM, Clementel D, Camagni GF, Minervini G, Tosatto SCE, Piovesan D. RING-PyMOL: residue interaction networks of structural ensembles and molecular dynamics. Bioinformatics 2023, 39.","DOI":"10.1093\/bioinformatics\/btad260"},{"key":"5664_CR33","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of Fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"5664_CR34","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47:W556\u201360.","journal-title":"Nucleic Acids Res"},{"key":"5664_CR35","doi-asserted-by":"publisher","first-page":"101858","DOI":"10.1016\/j.tranon.2023.101858","volume":"41","author":"Y Gao","year":"2024","unstructured":"Gao Y, Yu M, Liu Z, Liu Y, Kong Z, Zhu C, Qin X, Li Y, Tang L. m6A demethylase ALKBH5 maintains stemness of intrahepatic cholangiocarcinoma by sustaining BUB1B expression and cell proliferation. Translational Oncol. 2024;41:101858.","journal-title":"Translational Oncol"},{"key":"5664_CR36","doi-asserted-by":"publisher","first-page":"216144","DOI":"10.1016\/j.canlet.2023.216144","volume":"560","author":"D Xiang","year":"2023","unstructured":"Xiang D, Gu M, Liu J, Dong W, Yang Z, Wang K, Fu J, Wang H. m6A RNA methylation-mediated upregulation of HLF promotes intrahepatic cholangiocarcinoma progression by regulating the FZD4\/\u03b2-catenin signaling pathway. Cancer Lett. 2023;560:216144.","journal-title":"Cancer Lett"},{"key":"5664_CR37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12967-023-03897-y","volume":"21","author":"S Zhou","year":"2023","unstructured":"Zhou S, Yang K, Chen S, Lian G, Huang Y, Yao H, Zhao Y, Huang K, Yin D, Lin H, Li Y. CCL3 secreted by hepatocytes promotes the metastasis of intrahepatic cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (m(6)A) modification. J Transl Med. 2023;21:43.","journal-title":"J Transl Med"},{"key":"5664_CR38","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1158\/0008-5472.CAN-21-0468","volume":"81","author":"X Qiu","year":"2021","unstructured":"Qiu X, Yang S, Wang S, Wu J, Zheng B, Wang K, Shen S, Jeong S, Li Z, Zhu Y, et al. M(6)a demethylase ALKBH5 regulates PD-L1 expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma. Cancer Res. 2021;81:4778\u201393.","journal-title":"Cancer Res"},{"key":"5664_CR39","doi-asserted-by":"publisher","first-page":"27447","DOI":"10.1074\/jbc.M703098200","volume":"282","author":"YH Chi","year":"2007","unstructured":"Chi YH, Haller K, Peloponese JM Jr., Jeang KT. Histone acetyltransferase hALP and nuclear membrane protein hsSUN1 function in de-condensation of mitotic chromosomes. J Biol Chem. 2007;282:27447\u201358.","journal-title":"J Biol Chem"},{"key":"5664_CR40","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.molcel.2007.09.023","volume":"28","author":"D Fu","year":"2007","unstructured":"Fu D, Collins K. Purification of human telomerase complexes identifies factors involved in telomerase biogenesis and telomere length regulation. Mol Cell. 2007;28:773\u201385.","journal-title":"Mol Cell"},{"key":"5664_CR41","doi-asserted-by":"publisher","first-page":"35724","DOI":"10.1074\/jbc.C114.602698","volume":"289","author":"S Ito","year":"2014","unstructured":"Ito S, Horikawa S, Suzuki T, Kawauchi H, Tanaka Y, Suzuki T, Suzuki T. Human NAT10 is an ATP-dependent RNA acetyltransferase responsible for N4-acetylcytidine formation in 18 S ribosomal RNA (rRNA). J Biol Chem. 2014;289:35724\u201330.","journal-title":"J Biol Chem"},{"key":"5664_CR42","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s13046-022-02551-7","volume":"41","author":"C Jin","year":"2022","unstructured":"Jin C, Wang T, Zhang D, Yang P, Zhang C, Peng W, Jin K, Wang L, Zhou J, Peng C, et al. Acetyltransferase NAT10 regulates the Wnt\/\u03b2-catenin signaling pathway to promote colorectal cancer progression via ac4C acetylation of KIF23 mRNA. J Experimental Clin Cancer Res. 2022;41:345.","journal-title":"J Experimental Clin Cancer Res"},{"key":"5664_CR43","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13045-022-01338-9","volume":"15","author":"Z Feng","year":"2022","unstructured":"Feng Z, Li K, Qin K, Liang J, Shi M, Ma Y, Zhao S, Liang H, Han D, Shen B, et al. The LINC00623\/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modification of mRNA. J Hematol Oncol. 2022;15:112.","journal-title":"J Hematol Oncol"},{"key":"5664_CR44","doi-asserted-by":"publisher","first-page":"e738","DOI":"10.1002\/ctm2.738","volume":"12","author":"G Wang","year":"2022","unstructured":"Wang G, Zhang M, Zhang Y, Xie Y, Zou J, Zhong J, Zheng Z, Zhou X, Zheng Y, Chen B, Liu C. NAT10-mediated mRNA N4\u2010acetylcytidine modification promotes bladder cancer progression. Clin Translational Med. 2022;12:e738.","journal-title":"Clin Translational Med"},{"key":"5664_CR45","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1093\/nar\/gkaa130","volume":"48","author":"HY Liu","year":"2020","unstructured":"Liu HY, Liu YY, Yang F, Zhang L, Zhang FL, Hu X, Shao ZM, Li DQ. Acetylation of MORC2 by NAT10 regulates cell-cycle checkpoint control and resistance to DNA-damaging chemotherapy and radiotherapy in breast cancer. Nucleic Acids Res. 2020;48:3638\u201356.","journal-title":"Nucleic Acids Res"},{"key":"5664_CR46","doi-asserted-by":"crossref","unstructured":"Chen XW, Di YM, Zhang J, Zhou ZW, Li CG, Zhou SF. Interaction of herbal compounds with biological targets: a case study with berberine. ScientificWorldJournal 2012, 2012:708292.","DOI":"10.1100\/2012\/708292"},{"key":"5664_CR47","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.bcp.2012.07.018","volume":"84","author":"M Tillhon","year":"2012","unstructured":"Tillhon M, Guam\u00e1n Ortiz LM, Lombardi P, Scovassi AI. Berberine: new perspectives for old remedies. Biochem Pharmacol. 2012;84:1260\u20137.","journal-title":"Biochem Pharmacol"},{"key":"5664_CR48","doi-asserted-by":"publisher","first-page":"260464","DOI":"10.1155\/2013\/260464","volume":"2013","author":"M Zhang","year":"2013","unstructured":"Zhang M, Wang CM, Li J, Meng ZJ, Wei SN, Li J, Bucala R, Li YL, Chen L. Berberine protects against palmitate-induced endothelial dysfunction: involvements of upregulation of AMPK and eNOS and downregulation of NOX4. Mediators Inflamm. 2013;2013:260464.","journal-title":"Mediators Inflamm"},{"key":"5664_CR49","doi-asserted-by":"publisher","first-page":"117238","DOI":"10.1016\/j.jep.2023.117238","volume":"319","author":"X Ma","year":"2024","unstructured":"Ma X, Yu X, Li R, Cui J, Yu H, Ren L, Jiang J, Zhang W, Wang L. Berberine-silybin salt achieves improved anti-nonalcoholic fatty liver disease effect through regulating lipid metabolism. J Ethnopharmacol. 2024;319:117238.","journal-title":"J Ethnopharmacol"},{"key":"5664_CR50","doi-asserted-by":"publisher","first-page":"S429","DOI":"10.12980\/APJTB.4.2014C474","volume":"4","author":"E Heidarian","year":"2014","unstructured":"Heidarian E, Rafieian-Kopaei M, Khoshdel A, Bakhshesh M. Metabolic effects of berberine on liver phosphatidate phosphohydrolase in rats fed on high lipogenic diet: an additional mechanism for the hypolipidemic effects of berberine. Asian Pac J Trop Biomed. 2014;4:S429\u2013435.","journal-title":"Asian Pac J Trop Biomed"},{"key":"5664_CR51","doi-asserted-by":"publisher","first-page":"414","DOI":"10.2174\/1570159X11311040005","volume":"11","author":"N Ansari","year":"2013","unstructured":"Ansari N, Khodagholi F. Natural products as promising drug candidates for the treatment of Alzheimer\u2019s disease: molecular mechanism aspect. Curr Neuropharmacol. 2013;11:414\u201329.","journal-title":"Curr Neuropharmacol"},{"key":"5664_CR52","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1124\/mol.114.094037","volume":"86","author":"SC Chu","year":"2014","unstructured":"Chu SC, Yu CC, Hsu LS, Chen KS, Su MY, Chen PN. Berberine reverses epithelial-to-mesenchymal transition and inhibits metastasis and tumor-induced angiogenesis in human cervical cancer cells. Mol Pharmacol. 2014;86:609\u201323.","journal-title":"Mol Pharmacol"},{"key":"5664_CR53","first-page":"1221","volume":"34","author":"MS Choi","year":"2009","unstructured":"Choi MS, Oh JH, Kim SM, Jung HY, Yoo HS, Lee YM, Moon DC, Han SB, Hong JT. Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells. Int J Oncol. 2009;34:1221\u201330.","journal-title":"Int J Oncol"},{"key":"5664_CR54","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s00204-005-0014-8","volume":"80","author":"JM Hwang","year":"2006","unstructured":"Hwang JM, Kuo HC, Tseng TH, Liu JY, Chu CY. Berberine induces apoptosis through a mitochondria\/caspases pathway in human hepatoma cells. Arch Toxicol. 2006;80:62\u201373.","journal-title":"Arch Toxicol"},{"key":"5664_CR55","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.canlet.2007.09.007","volume":"258","author":"R Piyanuch","year":"2007","unstructured":"Piyanuch R, Sukhthankar M, Wandee G, Baek SJ. Berberine, a natural isoquinoline alkaloid, induces NAG-1 and ATF3 expression in human colorectal cancer cells. Cancer Lett. 2007;258:230\u201340.","journal-title":"Cancer Lett"},{"key":"5664_CR56","doi-asserted-by":"publisher","first-page":"113776","DOI":"10.1016\/j.bcp.2019.113776","volume":"174","author":"Y Liu","year":"2020","unstructured":"Liu Y, Hua W, Li Y, Xian X, Zhao Z, Liu C, Zou J, Li J, Fang X, Zhu Y. Berberine suppresses colon cancer cell proliferation by inhibiting the SCAP\/SREBP-1 signaling pathway-mediated lipogenesis. Biochem Pharmacol. 2020;174:113776.","journal-title":"Biochem Pharmacol"},{"key":"5664_CR57","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/13880209.2020.1865407","volume":"59","author":"G Li","year":"2021","unstructured":"Li G, Zhang C, Liang W, Zhang Y, Shen Y, Tian X. Berberine regulates the Notch1\/PTEN\/PI3K\/AKT\/mTOR pathway and acts synergistically with 17-AAG and SAHA in SW480 colon cancer cells. Pharm Biol. 2021;59:21\u201330.","journal-title":"Pharm Biol"},{"key":"5664_CR58","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.lfs.2017.11.012","volume":"192","author":"Y Xiao","year":"2018","unstructured":"Xiao Y, Tian C, Huang T, Han B, Wang M, Ma H, Li Z, Ye X, Li X. 8-Cetylberberine inhibits growth of lung cancer in vitro and in vivo. Life Sci. 2018;192:259\u201369.","journal-title":"Life Sci"},{"key":"5664_CR59","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1016\/j.bbamcr.2015.05.012","volume":"1853","author":"YH Su","year":"2015","unstructured":"Su YH, Tang WC, Cheng YW, Sia P, Huang CC, Lee YC, Jiang HY, Wu MH, Lai IL, Lee JW, Lee KH. Targeting of multiple oncogenic signaling pathways by Hsp90 inhibitor alone or in combination with berberine for treatment of colorectal cancer. Biochim Biophys Acta. 2015;1853:2261\u201372.","journal-title":"Biochim Biophys Acta"},{"key":"5664_CR60","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3727\/096504015X14298122915583","volume":"22","author":"SH Eo","year":"2014","unstructured":"Eo SH, Kim JH, Kim SJ. Induction of G\u2082\/M arrest by Berberine via activation of PI3K\/Akt and p38 in human Chondrosarcoma Cell line. Oncol Res. 2014;22:147\u201357.","journal-title":"Oncol Res"},{"key":"5664_CR61","doi-asserted-by":"publisher","first-page":"6797","DOI":"10.1111\/jcmm.14560","volume":"23","author":"X Gao","year":"2019","unstructured":"Gao X, Wang J, Li M, Wang J, Lv J, Zhang L, Sun C, Ji J, Yang W, Zhao Z, Mao W. Berberine attenuates XRCC1-mediated base excision repair and sensitizes breast cancer cells to the chemotherapeutic drugs. J Cell Mol Med. 2019;23:6797\u2013804.","journal-title":"J Cell Mol Med"},{"key":"5664_CR62","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.fertnstert.2015.01.010","volume":"103","author":"HL Wu","year":"2015","unstructured":"Wu HL, Chuang TY, Al-Hendy A, Diamond MP, Azziz R, Chen YH. Berberine inhibits the proliferation of human uterine leiomyoma cells. Fertil Steril. 2015;103:1098\u2013106.","journal-title":"Fertil Steril"},{"key":"5664_CR63","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1038\/s41375-022-01651-9","volume":"36","author":"P Feng","year":"2022","unstructured":"Feng P, Chen D, Wang X, Li Y, Li Z, Li B, Zhang Y, Li W, Zhang J, Ye J, et al. Inhibition of the m(6)a reader IGF2BP2 as a strategy against T-cell acute lymphoblastic leukemia. Leukemia. 2022;36:2180\u20138.","journal-title":"Leukemia"},{"key":"5664_CR64","first-page":"22","volume":"9","author":"P Luo","year":"2022","unstructured":"Luo P, Zhang Q, Zhong TY, Chen JY, Zhang JZ, Tian Y, Zheng LH, Yang F, Dai LY, Zou C, et al. Celastrol mitigates inflammation in sepsis by inhibiting the PKM2-dependent Warburg effect. Mil Med Res. 2022;9:22.","journal-title":"Mil Med Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05664-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05664-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05664-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T09:04:46Z","timestamp":1727687086000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05664-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5664"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05664-z","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,30]]},"assertion":[{"value":"19 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"875"}}